Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian K Link

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Current Hematologic Malignancy Reports|April 29, 2010
Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable?Brian K Link
Clinical Advances in Hematology & Oncology : H&O|July 8, 2014
Reassessing imaging surveillance in diffuse large B-cell lymphomaBrian K Link
The Journal of Allergy and Clinical Immunology|January 21, 2020
Immunologic dysfunction and Hodgkin lymphoma: Insight to better therapy?Brian K Link
Oncology (Williston Park, N.Y.)|March 28, 2013
Diffuse large B-cell lymphoma in the elderly: leaving our old way(s) behind?Brian K Link
Best Practice & Research. Clinical Haematology|February 18, 2018
Transformation of follicular lymphoma - Why does it happen and can it be prevented?Brian K Link
The Lancet. Haematology|November 4, 2018
Biosimilars: when a negative study can be positiveBrian K Link
Blood|June 5, 2020
Foreseeing what is to happen in DLBCLBrian K Link
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Will a Better Understanding of the Problem With Transformed Follicular Lymphoma Lead to Better Outcomes?Brian K Link
Haematologica|April 24, 2024
Follicular lymphoma treatment decisions: put GELF on the shelf?Brian K Link
Leukemia & Lymphoma|March 9, 2012
Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?Brian K Link
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Current Hematologic Malignancy Reports|April 29, 2010
Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable?Brian K Link
Clinical Advances in Hematology & Oncology : H&O|July 8, 2014
Reassessing imaging surveillance in diffuse large B-cell lymphomaBrian K Link
The Journal of Allergy and Clinical Immunology|January 21, 2020
Immunologic dysfunction and Hodgkin lymphoma: Insight to better therapy?Brian K Link
Oncology (Williston Park, N.Y.)|March 28, 2013
Diffuse large B-cell lymphoma in the elderly: leaving our old way(s) behind?Brian K Link
Best Practice & Research. Clinical Haematology|February 18, 2018
Transformation of follicular lymphoma - Why does it happen and can it be prevented?Brian K Link
The Lancet. Haematology|November 4, 2018
Biosimilars: when a negative study can be positiveBrian K Link
Blood|June 5, 2020
Foreseeing what is to happen in DLBCLBrian K Link
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Will a Better Understanding of the Problem With Transformed Follicular Lymphoma Lead to Better Outcomes?Brian K Link
Haematologica|April 24, 2024
Follicular lymphoma treatment decisions: put GELF on the shelf?Brian K Link
Leukemia & Lymphoma|March 9, 2012
Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?Brian K Link
Pageof 24